UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013005 |
|---|---|
| Receipt number | R000015178 |
| Scientific Title | Investigation about safety and utility of the new minimally invasive needle . |
| Date of disclosure of the study information | 2014/01/29 |
| Last modified on | 2014/07/30 19:29:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation about safety and utility of the new minimally invasive needle .
Acronym
Investigation about safety and utility of the new minimally invasive needle .
Scientific Title
Investigation about safety and utility of the new minimally invasive needle .
Scientific Title:Acronym
Investigation about safety and utility of the new minimally invasive needle .
Region
| Japan |
Condition
Condition
Hypertension and renal diseases
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
Investigation about safety and efficacy of the new minimally invasive needle
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Assessment
Primary outcomes
A questionnaire survey about the pain of patients and the facility of doctors.
Key secondary outcomes
SNPs
clinical blood test
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Device,equipment |
Interventions/Control_1
patients recieving treatments in Yokohama City University Hospital
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients recieving treatments in Yokohama City University Hospital participate in this clinical trial on their own.
Key exclusion criteria
patients with bleeding tendency or receiving anticoaglant and antiplatelet drugs.
Target sample size
4
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Keisuke Yatsu |
Organization
Yokohama City University Graduate School of Medicine
Division name
Medical Science and Cardiorenal Medicine
Zip code
Address
3-9 Fukuuura, Kanazawa-ku, Yokohama City
TEL
045-787-2635
k-yatsu@be.wakwak.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Keisuke Yatsu |
Organization
Yokohama City University Graduate School of Medicine
Division name
Medical Science and Cardiorenal Medicine
Zip code
Address
3-9 Fukuuura, Kanazawa-ku, Yokohama City
TEL
045-787-2635
Homepage URL
k-yatsu@be.wakwak.com
Sponsor or person
Institute
Yokohama City University Hospital
Institute
Department
Personal name
Funding Source
Organization
consigned research fund
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 01 | Month | 29 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 01 | Month | 09 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 01 | Month | 29 | Day |
Last follow-up date
| 2014 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
| 2014 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2014 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2014 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2014 | Year | 01 | Month | 29 | Day |
Last modified on
| 2014 | Year | 07 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015178
